STERIS Statistics
Total Valuation
STERIS has a market cap or net worth of $21.75 billion. The enterprise value is $23.38 billion.
| Market Cap | 21.75B |
| Enterprise Value | 23.38B |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | Feb 17, 2026 |
Share Statistics
STERIS has 98.08 million shares outstanding. The number of shares has decreased by -0.49% in one year.
| Current Share Class | 98.08M |
| Shares Outstanding | 98.08M |
| Shares Change (YoY) | -0.49% |
| Shares Change (QoQ) | -0.20% |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 96.74% |
| Float | 97.70M |
Valuation Ratios
The trailing PE ratio is 30.92 and the forward PE ratio is 20.52.
| PE Ratio | 30.92 |
| Forward PE | 20.52 |
| PS Ratio | 3.73 |
| Forward PS | 3.48 |
| PB Ratio | 3.04 |
| P/TBV Ratio | 17.67 |
| P/FCF Ratio | 23.71 |
| P/OCF Ratio | 17.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.84, with an EV/FCF ratio of 25.49.
| EV / Earnings | 33.03 |
| EV / Sales | 4.01 |
| EV / EBITDA | 14.84 |
| EV / EBIT | 21.47 |
| EV / FCF | 25.49 |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.29.
| Current Ratio | 2.48 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.25 |
| Debt / FCF | 2.24 |
| Interest Coverage | 17.35 |
Financial Efficiency
Return on equity (ROE) is 10.47% and return on invested capital (ROIC) is 9.39%.
| Return on Equity (ROE) | 10.47% |
| Return on Assets (ROA) | 6.61% |
| Return on Invested Capital (ROIC) | 9.39% |
| Return on Capital Employed (ROCE) | 11.26% |
| Weighted Average Cost of Capital (WACC) | 9.29% |
| Revenue Per Employee | $327,656 |
| Profits Per Employee | $39,790 |
| Employee Count | 17,787 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 4.91 |
Taxes
In the past 12 months, STERIS has paid $228.45 million in taxes.
| Income Tax | 228.45M |
| Effective Tax Rate | 24.30% |
Stock Price Statistics
The stock price has increased by +0.59% in the last 52 weeks. The beta is 1.04, so STERIS's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | +0.59% |
| 50-Day Moving Average | 245.43 |
| 200-Day Moving Average | 245.22 |
| Relative Strength Index (RSI) | 37.57 |
| Average Volume (20 Days) | 980,860 |
Short Selling Information
The latest short interest is 1.74 million, so 1.77% of the outstanding shares have been sold short.
| Short Interest | 1.74M |
| Short Previous Month | 1.56M |
| Short % of Shares Out | 1.77% |
| Short % of Float | 1.78% |
| Short Ratio (days to cover) | 1.74 |
Income Statement
In the last 12 months, STERIS had revenue of $5.83 billion and earned $707.74 million in profits. Earnings per share was $7.16.
| Revenue | 5.83B |
| Gross Profit | 2.58B |
| Operating Income | 1.09B |
| Pretax Income | 940.11M |
| Net Income | 707.74M |
| EBITDA | 1.57B |
| EBIT | 1.09B |
| Earnings Per Share (EPS) | $7.16 |
Balance Sheet
The company has $423.70 million in cash and $2.05 billion in debt, with a net cash position of -$1.63 billion or -$16.62 per share.
| Cash & Cash Equivalents | 423.70M |
| Total Debt | 2.05B |
| Net Cash | -1.63B |
| Net Cash Per Share | -$16.62 |
| Equity (Book Value) | 7.17B |
| Book Value Per Share | 72.93 |
| Working Capital | 1.36B |
Cash Flow
In the last 12 months, operating cash flow was $1.27 billion and capital expenditures -$349.69 million, giving a free cash flow of $917.10 million.
| Operating Cash Flow | 1.27B |
| Capital Expenditures | -349.69M |
| Depreciation & Amortization | 486.22M |
| Net Borrowing | -287.13M |
| Free Cash Flow | 917.10M |
| FCF Per Share | $9.35 |
Margins
Gross margin is 44.32%, with operating and profit margins of 18.68% and 12.14%.
| Gross Margin | 44.32% |
| Operating Margin | 18.68% |
| Pretax Margin | 16.13% |
| Profit Margin | 12.14% |
| EBITDA Margin | 27.02% |
| EBIT Margin | 18.68% |
| FCF Margin | 15.74% |
Dividends & Yields
This stock pays an annual dividend of $2.52, which amounts to a dividend yield of 1.14%.
| Dividend Per Share | $2.52 |
| Dividend Yield | 1.14% |
| Dividend Growth (YoY) | 10.31% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 34.35% |
| Buyback Yield | 0.49% |
| Shareholder Yield | 1.63% |
| Earnings Yield | 3.25% |
| FCF Yield | 4.22% |
Analyst Forecast
The average price target for STERIS is $275.20, which is 24.12% higher than the current price. The consensus rating is "Buy".
| Price Target | $275.20 |
| Price Target Difference | 24.12% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 6.84% |
| EPS Growth Forecast (5Y) | 15.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 25, 1998. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 25, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
STERIS has an Altman Z-Score of 5.49 and a Piotroski F-Score of 8.
| Altman Z-Score | 5.49 |
| Piotroski F-Score | 8 |